Filter Results :

Your search for Pharmaceuticals returned 5600 reports

Sort by


France Pharmaceuticals and Healthcare Report

25 Feb 2015  |  Published by:  BMI Pharmaceuticals and Healthcare
View: France will remain among the largest pharmaceutical markets worldwide in the coming years,especially due to a large and aging population, as well as high per capita spending levels on medicines.However, several cost-containment measures will continue to exert downward pressure on market growth...

$ 1,295.00

Read More

Canada Pharmaceuticals and Healthcare Report

25 Feb 2015  |  Published by:  BMI Pharmaceuticals and Healthcare
View: Supported by strong democratic institutions and a long history of stable political Leadership,Canada is home to the second largest pharmaceutical market in the Americas and one of the largest inworld. We believe that drugmakers will continue to realise considerable rewards, as sales of patente...

$ 1,295.00

Read More

Myanmar Pharmaceuticals and Healthcare Report

25 Feb 2015  |  Published by:  BMI Pharmaceuticals and Healthcare
View: New investment reforms lifting restrictions on the foreign funding of medicine production willmake Myanmar an attractive market to international generic drugmakers. This is due to the opportunity ofsecuring a first-mover advantage in this frontier market, as well as being a result of rising me...

$ 1,295.00

Read More

Lebanon Pharmaceuticals and Healthcare Report

25 Feb 2015  |  Published by:  BMI Pharmaceuticals and Healthcare
View: Lebanon's healthcare system is under enormous strain as the number of Syrian refugees seekingtreatment in the country has sharply risen. Continued political instability will negatively impact governmentpolicy regarding healthcare and will in turn put the pharmaceutical sector at risk. However,...

$ 1,295.00

Read More

Slovenia Pharmaceuticals and Healthcare Report

25 Feb 2015  |  Published by:  BMI Pharmaceuticals and Healthcare
View: Our updated forecasts for Slovenia's pharmaceutical and healthcare expenditure indicate arebound this year from a decline trend that was seen over the past three years. Admittedly, this is true inlocal currency terms, while the value in USD is expected to take a significant hit, especially inp...

$ 1,295.00

Read More

Romania Pharmaceuticals and Healthcare Report

25 Feb 2015  |  Published by:  BMI Pharmaceuticals and Healthcare
View: We expect Romania's pharmaceutical market in 2015 to be initially driven by a consumer-ledrecovery as falling fuel and food prices, rising wages and declining unemployment drive pharmaceuticalconsumption, but local regulatory factors such as revenue taxes will continue to present obstacles tog...

$ 1,295.00

Read More

Singapore Pharmaceuticals and Healthcare Report

18 Feb 2015  |  Published by:  BMI Pharmaceuticals and Healthcare
View: Singapore will remain a highly attractive manufacturing base for international pharmaceuticalcompanies due to minimal levels of operational risks and the government's support for the industry. Thepharmaceutical industry has been a key pillar of the country's economy and we believe its importan...

$ 1,295.00

Read More

Hong Kong Pharmaceuticals and Healthcare Report

18 Feb 2015  |  Published by:  BMI Pharmaceuticals and Healthcare
View: The Hong Kong government will continue to shift healthcare provision towards the privatesector due to the growing financial strain and an overburdened public healthcare system. While this couldcreate cost barriers to medicines, we highlight that the strong earning power of the majority of thep...

$ 1,295.00

Read More

Japan Pharmaceuticals and Healthcare Report

18 Feb 2015  |  Published by:  BMI Pharmaceuticals and Healthcare
View: Japan's healthcare system will come under increasing financial strain due to the ageingpopulation and the high use of patented medicines. This provides an impetus for the government to use costcontainment measures including policies to encourage the uptake of generic drug medicines, posing ado...

$ 1,295.00

Read More

New Zealand Pharmaceuticals and Healthcare Report

18 Feb 2015  |  Published by:  BMI Pharmaceuticals and Healthcare
View: Despite policy initiatives designed to increase the pace of generic penetration, high latentdemand for branded pharmaceuticals will continue to be underpinned by New Zealand's ageing andexpanding population. However, the conversion of such potential into rewards for multinationals willremain l...

$ 1,295.00

Read More

Mauritius Pharmaceuticals and Healthcare Report

18 Feb 2015  |  Published by:  BMI Pharmaceuticals and Healthcare
View: With high per-capita pharmaceutical expenditure and a stong governmental interest inpharmaceutical development, combined with a rising demand for non-communicable and chronic diseasetherapies, Mauritius plays host as an attractive destination for future growth - although the destination stillr...

$ 1,295.00

Read More

Tanzania Pharmaceuticals and Healthcare Report

18 Feb 2015  |  Published by:  BMI Pharmaceuticals and Healthcare
View: Tanzania's pharmaceutical market will continue to see growth with the continuing expansion ofthe country's National Health Insurance Fund. We highlight opportunities in the Tanzanian healthcaremarket which have come about thanks to the government's plans to introduce compulsory health insuranc...

$ 1,295.00

Read More

Bulgaria Pharmaceuticals and Healthcare Report

18 Feb 2015  |  Published by:  BMI Pharmaceuticals and Healthcare
View: In 2015, we expect the fallout from the banking and NHIF funding crises to impactpharmaceutical and healthcare spending, but given the passage of reforms to healthcare financing, we holda more positive view for the long term development of the pharmaceutical & healthcare sector.Headline Expend...

$ 1,295.00

Read More

Argentina Pharmaceuticals and Healthcare Report

18 Feb 2015  |  Published by:  BMI Pharmaceuticals and Healthcare
View: Despite economic activity forecast to continue to decline over the medium-term, Argentina'sgradual transition towards more pragmatic and market-friendly economic policies will likely benefit keyeconomic sectors in the long-term, including the pharmaceutical industry. We sustain our view thatun...

$ 1,295.00

Read More

Poland Pharmaceuticals and Healthcare Report

18 Feb 2015  |  Published by:  BMI Pharmaceuticals and Healthcare
View: The Polish pharmaceutical market is heavily dependent on public healthcare spending; anynegative economic developments will have an impact on the market in the short term. Over the past fiveyears, Poland's economic outperformance has been vital to maintaining positive growth for the private an...

$ 1,295.00

Read More
Total 5600 records.